Rochester, MN, United States of America

Timothy Carey

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Regeneron Pharmaceuticals, Inc., Vyriad, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Timothy Carey. Retrieved from https://idiyas.com/inventor/timothy-carey-6r6f384p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Timothy Carey

Introduction

Timothy Carey is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of medical technology, particularly in the area of coronavirus research. His innovative work has led to the development of a patent that addresses critical health challenges.

Latest Patents

Timothy Carey holds a patent for "Detection Assays for Coronavirus Neutralizing Antibodies." This patent represents a vital advancement in the detection and understanding of neutralizing antibodies, which are crucial for combating viral infections.

Career Highlights

Throughout his career, Timothy has worked with notable companies such as Vyriad, Inc. and Regeneron Pharmaceuticals, Inc. His experience in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Timothy has collaborated with talented individuals in his field, including Stephen James Russell and Patrycja Lech. These partnerships have fostered innovation and have been instrumental in advancing their shared goals in medical research.

Conclusion

Timothy Carey is a notable inventor whose work in coronavirus detection has made a significant impact. His contributions to the field highlight the importance of innovation in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…